Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jun 05 2026

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-jun-05-2026-5

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 05, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases